The Netherlands Organization for Scientific Research (NWO) has awarded a Vici grant of a maximum of 1.5 million euros to GRIAC researcher Gerard Koppelman. He can use this to develop an innovative research line and build up his own research over a period of five years.

Early diagnosis of asthma in young children

In his study 'Early diagnosis and targeted treatment of the development of asthma in children' Gerard Koppelman is looking for a method to diagnose asthma in young children at an early stage. It is currently not possible to diagnose or specifically treat asthma in the first years of life. Koppelman wants to change that. “We want to investigate which factors indicate the development of asthma in young children (1-3 years old). In this study, Koppelman is investigating whether it is possible to diagnose asthma at an early stage with a DNA test of nasal cells. In developing new asthma treatments, he focuses on airway cells that are involved in the inception  of asthma. “If we can diagnose and treat asthma at a young age, we hope to prevent the development of the chronic airway inflammation that is present later in life. With the ultimate goal of being able to cure asthma in the future.”

The Vici grant

Together with the Veni and Vidi grants, the Vici grant is part of the NWO Talent Programme. Within the Talent Programme, researchers are free to submit their own subject for funding. This way, NWO stimulates curiosity-driven and innovative research. NWO selects researchers based on the quality of the researcher, the innovative nature of the research, the expected scientific impact of the research proposal and possibilities for knowledge utilisation.


​​​​​This news is related to Groningen Research Institute for Asthma and COPD (GRIAC)